Twenty-four patients with chronic hepatitis B virus ( HBV ) , antibody to hepatitis B e antigen ( anti-HBe ) , HBV DNA positivity , and alanine transaminase ( ALT ) elevation who failed previous interferon alfa ( IFN-alpha ) therapy were included in a pilot study of combination therapy with ribavirin and IFN-alpha .